Ifg Advisory, LLC Cellectis S.A. Transaction History

Ifg Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$15.58 - $28.41 $164,244 - $299,498	-10,542 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$25.99 - $30.6 $4,418 - $5,202	-170 Reduced 1.59%	10,542 $297,000
Q2 2018 Aug 02, 2018	BUY	$27.78 - $38.53 $39,586 - $54,905	1,425 Added 15.34%	10,712 $303,000
Q1 2018 Apr 26, 2018	BUY	$27.78 - $35.19 $257,992 - $326,809	9,287 New	9,287 $0

14.2M

3.1K

1.7K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $63.3M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Ifg Advisory, LLC with notifications on news.